Ocuphire Pharma, Inc.(OCUP)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

OCUP Ocuphire Pharma, Inc.

休市中 05-17 16:00:00 EDT

1.69

-0.05

-2.88%

盘后1.67

-0.01-0.82%

17:22 EDT

最高1.79	最低1.68	成交量11.45万
今开1.75	昨收1.74	日振幅6.10%
总市值4,315万	流通市值4,064万	总股本2,561万
成交额19.80万	换手率0.47%	流通股本2,412万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"OCUP","market":"US","secType":"STK","nameCN":"Ocuphire Pharma, Inc.","latestPrice":1.685,"timestamp":1715976000000,"preClose":1.735,"halted":0,"volume":114524,"hourTrading":{"tag":"盘后","latestPrice":1.6712,"preClose":1.685,"latestTime":"17:22 EDT","volume":250,"amount":417.62,"timestamp":1715980924794},"delay":0,"floatShares":24117806,"shares":25608506,"eps":-0.5026,"marketStatus":"休市中","marketStatusCode":7,"change":-0.05,"latestTime":"05-17 16:00:00 EDT","open":1.75,"high":1.7858,"low":1.68,"amount":197992.0917288,"amplitude":0.06098,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.5026,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1716192000000},"adr":0,"listingDate":1100235600000,"adjPreClose":1.735,"postHourTrading":{"tag":"盘后","latestPrice":1.6712,"preClose":1.685,"latestTime":"17:22 EDT","volume":250,"amount":417.62,"timestamp":1715980924794},"volumeRatio":0.6007816396909428},"requestUrl":"/m/hq/s/OCUP","defaultTab":"news","newsList":[{"id":"2435258373","title":"Ocuphire Pharma, Inc.盘中异动 股价大涨5.23%报1.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435258373","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2435258373?lang=zh_cn&edition=full","pubTime":"2024-05-13 21:38","pubTimestamp":1715607500,"startTime":"0","endTime":"0","summary":"北京时间2024年05月13日21时38分，Ocuphire Pharma, Inc.股票出现异动，股价快速拉升5.23%。Ocuphire Pharma, Inc.股票所在的生物技术行业中，整体涨幅为1.03%。Ocuphire Pharma, Inc.公司简介：Ocuphire Pharma Inc 是一家临床阶段的眼科生物制药公司，专注于开发和商业化治疗屈光和视网膜眼部疾病的疗法。Ocuphire的产品线包括两种小分子产品候选药，针对眼部前段和后段疾病指标。该信息摘要如下：HC Wainwright & Co.：重申Ocuphire Pharma评级，由买入调整至买入评级, 目标价20.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513213820861ecce6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513213820861ecce6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2434868583","title":"Ocuphire Pharma, Inc.盘中异动 股价大跌5.10%报1.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434868583","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2434868583?lang=zh_cn&edition=full","pubTime":"2024-05-10 23:02","pubTimestamp":1715353371,"startTime":"0","endTime":"0","summary":"北京时间2024年05月10日23时02分，Ocuphire Pharma, Inc.股票出现异动，股价急速下跌5.10%。截至发稿，该股报1.86美元/股，成交量4.1612万股，换手率0.16%，振幅6.12%。Ocuphire Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。Ocuphire Pharma, Inc.公司简介：Ocuphire Pharma Inc 是一家临床阶段的眼科生物制药公司，专注于开发和商业化治疗屈光和视网膜眼部疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405102302527a594339&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405102302527a594339&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2434850192","title":"Ocuphire Pharma Inc    预计每股亏损 12 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2434850192","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2434850192?lang=zh_cn&edition=full","pubTime":"2024-05-10 22:47","pubTimestamp":1715352420,"startTime":"0","endTime":"0","summary":"   * Ocuphire Pharma Inc    预计将在5月13日公布截至2024年6月30日的业绩报告时显示季度收入增长(预计)    * 根据LSEG的数据，4位分析师的平均预期显示，这家总部位于密歇根州法明顿希尔斯的公司的营收将从去年同期的367万美元增长25.4%，达到460.6万美元。* LSEG 分析师对 Ocuphire Pharma Inc 的平均预期是每股亏损 12 美分。* 华尔街对 Ocuphire Pharma Inc 的 12 个月目标价中位数为 20.00 美元，高于其最新收盘价 1.96 美元。5月10日 - 本摘要于北京时间 5 月 10 日 14:46 机器生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2434370770","title":"Ocuphire Pharma, Inc.盘中异动 下午盘股价大跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434370770","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2434370770?lang=zh_cn&edition=full","pubTime":"2024-05-09 02:49","pubTimestamp":1715194175,"startTime":"0","endTime":"0","summary":"北京时间2024年05月09日02时49分，Ocuphire Pharma, Inc.股票出现异动，股价大幅下跌5.15%。Ocuphire Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.45%。Ocuphire Pharma, Inc.公司简介：Ocuphire Pharma Inc 是一家临床阶段的眼科生物制药公司，专注于开发和商业化治疗屈光和视网膜眼部疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050902493687e86802&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050902493687e86802&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433180470","title":"Ocuphire Pharma, Inc.盘中异动 股价大涨6.03%报2.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433180470","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433180470?lang=zh_cn&edition=full","pubTime":"2024-05-06 22:39","pubTimestamp":1715006343,"startTime":"0","endTime":"0","summary":"北京时间2024年05月06日22时39分，Ocuphire Pharma, Inc.股票出现异动，股价大幅上涨6.03%。Ocuphire Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.04%。其相关个股中，Tc Biopharm  Plc、Nrx Pharmaceuticals, Inc.、Jasper Therapeutics Inc C/Wts 24/09/2026 涨幅较大，Tc Biopharm  Plc、Allarity Therapeutics, Inc.、Lyra Therapeutics, Inc.较为活跃，换手率分别为1055.81%、693.65%、62.63%，振幅较大的相关个股有Tc Biopharm  Plc C/Wts 10/02/2028 、Tc Biopharm  Plc、Nrx Pharmaceuticals, Inc.，振幅分别为95.51%、84.25%、40.00%。Ocuphire Pharma, Inc.公司简介：Ocuphire Pharma Inc 是一家临床阶段的眼科生物制药公司，专注于开发和商业化治疗屈光和视网膜眼部疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240506223903861eb350&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240506223903861eb350&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432050909","title":"Ocuphire Pharma, Inc.盘中异动 早盘快速上涨7.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432050909","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432050909?lang=zh_cn&edition=full","pubTime":"2024-05-03 22:41","pubTimestamp":1714747267,"startTime":"0","endTime":"0","summary":"北京时间2024年05月03日22时41分，Ocuphire Pharma, Inc.股票出现异动，股价快速上涨7.03%。Ocuphire Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.43%。Ocuphire Pharma, Inc.公司简介：Ocuphire Pharma Inc 是一家临床阶段的眼科生物制药公司，专注于开发和商业化治疗屈光和视网膜眼部疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405032241077925c230&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405032241077925c230&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432838609","title":"Ocuphire Pharma, Inc.盘中异动 股价大涨5.30%报1.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432838609","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432838609?lang=zh_cn&edition=full","pubTime":"2024-05-02 22:38","pubTimestamp":1714660731,"startTime":"0","endTime":"0","summary":"北京时间2024年05月02日22时38分，Ocuphire Pharma, Inc.股票出现波动，股价急速上涨5.30%。截至发稿，该股报1.73美元/股，成交量2.8192万股，换手率0.11%，振幅4.27%。Ocuphire Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.31%。Ocuphire Pharma, Inc.公司简介：Ocuphire Pharma Inc 是一家临床阶段的眼科生物制药公司，专注于开发和商业化治疗屈光和视网膜眼部疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405022238517a57ed9b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405022238517a57ed9b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431896872","title":"Ocuphire Pharma, Inc.盘中异动 大幅上涨6.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431896872","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431896872?lang=zh_cn&edition=full","pubTime":"2024-04-29 23:22","pubTimestamp":1714404168,"startTime":"0","endTime":"0","summary":"北京时间2024年04月29日23时22分，Ocuphire Pharma, Inc.股票出现异动，股价急速上涨6.21%。Ocuphire Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.81%。其相关个股中，Nkgen Biotech Inc C/Wts 31/05/2028、Zura Bio Limited C/Wts 、Soleno Therapeutics, Inc.涨幅较大，Zyversa Therapeutics, Inc.、Biodexa Pharmaceuticals Plc、Avenue Therapeutics, Inc.较为活跃，换手率分别为948.56%、44.32%、21.05%，振幅较大的相关个股有Annovis Bio, Inc.、Cassava Sciences Inc C/Wts 15/11/2024、Ginkgo Bioworks Holdings, Inc.，振幅分别为67.63%、33.33%、31.39%。Ocuphire Pharma, Inc.公司简介：Ocuphire Pharma Inc 是一家临床阶段的眼科生物制药公司，专注于开发和商业化治疗屈光和视网膜眼部疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404292322487a573b67&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404292322487a573b67&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429874924","title":"Ocuphire Pharma, Inc.盘中异动 早盘急速下跌5.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429874924","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429874924?lang=zh_cn&edition=full","pubTime":"2024-04-22 21:36","pubTimestamp":1713793003,"startTime":"0","endTime":"0","summary":"北京时间2024年04月22日21时36分，Ocuphire Pharma, Inc.股票出现异动，股价大幅下跌5.79%。Ocuphire Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.45%。Ocuphire Pharma, Inc.公司简介：Ocuphire Pharma Inc 是一家临床阶段的眼科生物制药公司，专注于开发和商业化治疗屈光和视网膜眼部疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042221364487e827f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042221364487e827f7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427007925","title":"Ocuphire Pharma, Inc.盘中异动 股价大跌5.43%报1.74美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427007925","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427007925?lang=zh_cn&edition=full","pubTime":"2024-04-15 22:56","pubTimestamp":1713192985,"startTime":"0","endTime":"0","summary":"北京时间2024年04月15日22时56分，Ocuphire Pharma, Inc.股票出现异动，股价快速跳水5.43%。截至发稿，该股报1.74美元/股，成交量5.6301万股，换手率0.23%，振幅5.43%。Ocuphire Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.43%。Ocuphire Pharma, Inc.公司简介：Ocuphire Pharma Inc 是一家临床阶段的眼科生物制药公司，专注于开发和商业化治疗屈光和视网膜眼部疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415225625861e5d78&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415225625861e5d78&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427752906","title":"Ocuphire Pharma, Inc.盘中异动 临近收盘股价大涨5.03%报1.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427752906","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427752906?lang=zh_cn&edition=full","pubTime":"2024-04-13 03:36","pubTimestamp":1712950589,"startTime":"0","endTime":"0","summary":"北京时间2024年04月13日03时36分，Ocuphire Pharma, Inc.股票出现波动，股价大幅拉升5.03%。截至发稿，该股报1.88美元/股，成交量45.0969万股，换手率1.82%，振幅9.50%。Ocuphire Pharma, Inc.股票所在的生物技术行业中，整体跌幅为1.67%。Ocuphire Pharma, Inc.公司简介：Ocuphire Pharma Inc 是一家临床阶段的眼科生物制药公司，专注于开发和商业化治疗屈光和视网膜眼部疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240413033630861e561d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240413033630861e561d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424392459","title":"Ocuphire Pharma, Inc.盘中异动 股价大涨5.15%报2.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2424392459","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424392459?lang=zh_cn&edition=full","pubTime":"2024-04-04 21:43","pubTimestamp":1712238193,"startTime":"0","endTime":"0","summary":"北京时间2024年04月04日21时43分，Ocuphire Pharma, Inc.股票出现异动，股价急速拉升5.15%。Ocuphire Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.60%。Ocuphire Pharma, Inc.公司简介：Ocuphire Pharma Inc 是一家临床阶段的眼科生物制药公司，专注于开发和商业化治疗屈光和视网膜眼部疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040421431487e7e06b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040421431487e7e06b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424878885","title":"Ocuphire Pharma, Inc.盘中异动 股价大跌5.96%报2.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2424878885","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424878885?lang=zh_cn&edition=full","pubTime":"2024-04-04 01:58","pubTimestamp":1712167093,"startTime":"0","endTime":"0","summary":"北京时间2024年04月04日01时58分，Ocuphire Pharma, Inc.股票出现波动，股价大幅跳水5.96%。Ocuphire Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。Ocuphire Pharma, Inc.公司简介：Ocuphire Pharma Inc 是一家临床阶段的眼科生物制药公司，专注于开发和商业化治疗屈光和视网膜眼部疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404040158137a50fcec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404040158137a50fcec&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421046189","title":"Ocuphire Pharma, Inc.盘中异动 大幅拉升6.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421046189","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421046189?lang=zh_cn&edition=full","pubTime":"2024-03-21 21:38","pubTimestamp":1711028295,"startTime":"0","endTime":"0","summary":"北京时间2024年03月21日21时38分，Ocuphire Pharma, Inc.股票出现异动，股价急速拉升6.06%。Ocuphire Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.57%。Ocuphire Pharma, Inc.公司简介：Ocuphire Pharma Inc 是一家临床阶段的眼科生物制药公司，专注于开发和商业化治疗屈光和视网膜眼部疾病的疗法。消息层面，截至21时38分，《Ocuphire PharmaMagrath George增持2.5万股普通股股份，价值约4.91万美元》资讯为影响Ocuphire Pharma, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240321213815861e0188&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240321213815861e0188&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419974272","title":"Ocuphire Pharma, Inc.盘中异动 快速上涨5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419974272","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419974272?lang=zh_cn&edition=full","pubTime":"2024-03-15 21:33","pubTimestamp":1710509585,"startTime":"0","endTime":"0","summary":"北京时间2024年03月15日21时33分，Ocuphire Pharma, Inc.股票出现异动，股价急速上涨5.29%。Ocuphire Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.35%。其相关个股中，Better Therapeutics, Inc.、杰龙、Jasper Therapeutics Inc C/Wts 24/09/2026 涨幅较大，Better Therapeutics, Inc.、Galmed Pharmaceuticals Ltd.、Kintara Therapeutics, Inc.较为活跃，换手率分别为126.30%、60.67%、10.32%，振幅较大的相关个股有Better Therapeutics, Inc.、联拓生物、Cassava Sciences Inc C/Wts 15/11/2024，振幅分别为21.14%、15.21%、13.95%。Ocuphire Pharma, Inc.公司简介：Ocuphire Pharma Inc 是一家临床阶段的眼科生物制药公司，专注于开发和商业化治疗屈光和视网膜眼部疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031521330687e79572&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031521330687e79572&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419265371","title":"Ocuphire Pharma, Inc.盘中异动 股价大跌5.14%报2.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419265371","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419265371?lang=zh_cn&edition=full","pubTime":"2024-03-14 02:01","pubTimestamp":1710352919,"startTime":"0","endTime":"0","summary":"北京时间2024年03月14日02时01分，Ocuphire Pharma, Inc.股票出现异动，股价大幅下挫5.14%。截至发稿，该股报2.03美元/股，成交量9.0902万股，换手率0.37%，振幅6.07%。Ocuphire Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.14%。Ocuphire Pharma, Inc.公司简介：Ocuphire Pharma Inc 是一家临床阶段的眼科生物制药公司，专注于开发和商业化治疗屈光和视网膜眼部疾病的疗法。Ocuphire 的管线包括两个针对眼前部和背面部适应症的小分子候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031402020087e7899d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031402020087e7899d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2418368142","title":"Ocuphire Pharma, Inc.盘中异动 大幅上涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2418368142","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2418368142?lang=zh_cn&edition=full","pubTime":"2024-03-11 21:38","pubTimestamp":1710164280,"startTime":"0","endTime":"0","summary":"北京时间2024年03月11日21时38分，Ocuphire Pharma, Inc.股票出现异动，股价急速拉升5.03%。Ocuphire Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.52%。其相关个股中，Biocardia Inc C/Wts 06/08/2024、Tc Biopharm  Plc C/Wts 10/02/2028 、Tc Biopharm  Plc涨幅较大，Tc Biopharm  Plc、180 Life Sciences Corp.、Sonnet Biotherapeutics Holdings, Inc.较为活跃，换手率分别为850.01%、156.02%、71.85%，振幅较大的相关个股有Tc Biopharm  Plc C/Wts 10/02/2028 、Tc Biopharm  Plc、Equillium, Inc.，振幅分别为46.67%、32.08%、14.23%。Ocuphire Pharma, Inc.公司简介：Ocuphire Pharma Inc 是一家临床阶段的眼科生物制药公司，专注于开发和商业化治疗屈光和视网膜眼部疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403112138007a4b9396&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403112138007a4b9396&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2413040878","title":"Ocuphire Pharma Inc盘中异动 股价大跌5.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2413040878","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2413040878?lang=zh_cn&edition=full","pubTime":"2024-02-22 03:21","pubTimestamp":1708543293,"startTime":"0","endTime":"0","summary":"北京时间2024年02月22日03时21分，Ocuphire Pharma Inc股票出现波动，股价大幅下跌5.76%。Ocuphire Pharma Inc股票所在的生物技术行业中，整体跌幅为0.21%。Ocuphire Pharma Inc公司简介：Ocuphire Pharma Inc 是一家临床阶段的眼科生物制药公司，专注于开发和商业化治疗屈光和视网膜眼部疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022203213387e71ef7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022203213387e71ef7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2409726892","title":"Ocuphire Pharma Inc盘中异动 股价大跌5.04%报2.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2409726892","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2409726892?lang=zh_cn&edition=full","pubTime":"2024-02-08 01:07","pubTimestamp":1707325673,"startTime":"0","endTime":"0","summary":"北京时间2024年02月08日01时07分，Ocuphire Pharma Inc股票出现异动，股价大幅跳水5.04%。截至发稿，该股报2.45美元/股，成交量9.6649万股，换手率0.40%，振幅6.20%。Ocuphire Pharma Inc股票所在的生物技术行业中，整体涨幅为1.02%。Ocuphire Pharma Inc公司简介：Ocuphire Pharma Inc 是一家临床阶段的眼科生物制药公司，专注于开发和商业化治疗屈光和视网膜眼部疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024020801075387e6ee40&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024020801075387e6ee40&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ocuphire.com","stockEarnings":[{"period":"1week","weight":-0.0203},{"period":"1month","weight":-0.0316},{"period":"3month","weight":-0.3593},{"period":"6month","weight":-0.4249},{"period":"1year","weight":-0.6126},{"period":"ytd","weight":-0.4402}],"compareEarnings":[{"period":"1week","weight":0.0165},{"period":"1month","weight":0.0577},{"period":"3month","weight":0.0599},{"period":"6month","weight":0.1745},{"period":"1year","weight":0.2629},{"period":"ytd","weight":0.1139}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Ocuphire Pharma, Inc.是一家临床阶段的眼科生物制药公司，致力于开发和商业化用于治疗多种眼疾的疗法。Ocuphire的产品线目前包括针对眼部适应症的两种小分子候选产品。该公司的主要产品候选产品Nyxol眼药水是一种每日一次无防腐剂的甲磺酸酚妥拉明的眼药水配方，一种非选择性的α-1和α-2肾上腺素能拮抗剂，旨在减少瞳孔大小，目前正在开发有几种适应症，包括昏暗的灯光或夜视障碍，药理性散瞳和老花眼。Ocuphire的第二个候选产品APX3330是每天两次的口服片剂，旨在抑制与视网膜和脉络膜血管疾病（例如糖尿病性视网膜病变和糖尿病性黄斑水肿）相关的血管生成和炎症途径。","yearOnYearQuotes":[{"month":1,"riseRate":0.45,"avgChangeRate":0.081272},{"month":2,"riseRate":0.5,"avgChangeRate":0.063536},{"month":3,"riseRate":0.35,"avgChangeRate":0.008391},{"month":4,"riseRate":0.421053,"avgChangeRate":0.546155},{"month":5,"riseRate":0.6,"avgChangeRate":4.574798},{"month":6,"riseRate":0.421053,"avgChangeRate":-0.013261},{"month":7,"riseRate":0.315789,"avgChangeRate":-0.019252},{"month":8,"riseRate":0.368421,"avgChangeRate":-0.005969},{"month":9,"riseRate":0.421053,"avgChangeRate":-0.027171},{"month":10,"riseRate":0.263158,"avgChangeRate":-0.107261},{"month":11,"riseRate":0.315789,"avgChangeRate":-0.064728},{"month":12,"riseRate":0.45,"avgChangeRate":0.058972}],"exchange":"NASDAQ","name":"Ocuphire Pharma, Inc.","nameEN":"Ocuphire Pharma, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Ocuphire Pharma, Inc.(OCUP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Ocuphire Pharma, Inc.(OCUP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Ocuphire Pharma, Inc.,OCUP,Ocuphire Pharma, Inc.股票,Ocuphire Pharma, Inc.股票老虎,Ocuphire Pharma, Inc.股票老虎国际,Ocuphire Pharma, Inc.行情,Ocuphire Pharma, Inc.股票行情,Ocuphire Pharma, Inc.股价,Ocuphire Pharma, Inc.股市,Ocuphire Pharma, Inc.股票价格,Ocuphire Pharma, Inc.股票交易,Ocuphire Pharma, Inc.股票购买,Ocuphire Pharma, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Ocuphire Pharma, Inc.(OCUP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Ocuphire Pharma, Inc.(OCUP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}